Evidence map›Paper›PMID 36966311›Full record

ArticleCancer cell international2023

A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis.

Ran Hao, Lei Zhang, Yangming Si, Peng Zhang, Yipeng Wang, Bangchao Li, Jie Hu, Yixin Qi

Open access · goldFull text read
In one paragraph

Article in Cancer cell international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. NSUN2-mediated m5C hypermethylation ofNon-coding RNA research · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ran Hao *Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China.
Lei Zhang *Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China.
Yangming Si *School of Physical Science and Technology, Inner Mongolia University, Hohhot, Inner Mongolia, China.
Peng ZhangInstitutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China.
Yipeng WangInstitutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China.
Bangchao LiDepartment of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Jie HuDepartment of Science and Technology, Hebei Medical University, Shijiazhuang, Hebei, China. Hujie@hebmu.edu.cn.
Yixin QiDepartment of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. qiyixin@hebmu.edu.cn.
Hebei Medical University · CNArmy Medical University · CNHebei University of Science and Technology · CNInner Mongolia University · CN

Funding

Natural Science Foundation of Hebei Province H2020206483Natural Science Foundation of Hebei Province H2021206289S&T Program of Hebei 19277799DS&T Program of Hebei 21377729D
6 · The paper itself

Abstract

backgroundMetastasis is the leading cause of mortality in patients with breast cancer (BC). Studies demonstrate that circular RNAs (circRNAs) were involved in BC progression, while the molecular mechanisms remain largely unclear.

methodsThe microArray circRNA profiles were used to explore the differential expression circRNAs in BC and paracancerous normal tissues, and the quantitative reverse transcription-polymerase chain reaction was used to validate their expression level in clinical samples and cell lines. Nuclear/cytosolic fractionation and fluorescence in situ hybridization (FISH) assays were performed to examine circRRM2 (hsa_circ_0052582) subcellular location. The scratch wound healing and transwell assays were conducted to evaluate the impact of circRRM2 on BC cell migration and invasion. We predicted miRNAs that might bind with cricRRM2 and the downstream target genes using bioinformatics analysis and explored their expression levels and prognostic value in BC. FISH, RNA immunoprecipitation, Co-immunoprecipitation, Western blot, and rescue experiments were implemented to figure out circRRM2 function and underlying mechanisms in BC.

resultsThe present study revealed several aberrant circRNAs in BC tissues and observed that circRRM2 was upregulated in tumor tissues of 40 patients with BC. High circRRM2 was significantly associated with advanced N stage in patients with BC. Gain- and loss- of function experiments revealed that circRRM2 promoted the migration and invasion of cells and functioned as an oncogene in BC. Mechanism studies showed that circRRM2 competed with miR-31-5p/miR-27b-3p to upregulate the IGF2BP1 expression. Furthermore, IGF2BP1 upregulated the circRRM2 level via interacting with MYC, which functioned as the transcriptional factor of circRRM2. Thus, the positive feedback loop that was composed of circRRM2/IGF2BP1/MYC was identified.

conclusionThis study confirms that upregulated circRRM2 functions an oncogenic role in BC metastasis. The positive feedback loop of circRRM2/IGF2BP1/MYC enforces the circRRM2 expression, which might offer a potential target for BC treatment.

Indexed as

Breast cancerCircular RNAFeedback loopMetastasisMYC

Identifiers

PMID36966311
PMCPMC10039515
OpenAlexW4360949793

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read42
table measurements read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.